Clinical Trial Update: Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of QAW039 in adults with moderate-to-severe Atopic Dermatitis has been completed. Results were posted December …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• QAW039

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2015-12-15